FINWIRES · TerminalLIVE
FINWIRES

最新消息：市场动态：Coinbase Global和Gemini Titan因预测市场涉嫌非法赌博被纽约州起诉

-- （第四段更新了 Coinbase 的声明。） 据路透社周二报道，纽约州总检察长莱蒂西亚·詹姆斯 (Letitia James) 已对 Coinbase Global (COIN) 和 Gemini Titan 提起诉讼，指控其预测市场涉嫌违反纽约州禁止非法赌博的法律。报道援引了曼哈顿州法院收到的诉状。 报道称，詹姆斯表示，这两家公司未就其预测市场向纽约州博彩委员会申请许可证，而这些市场符合该州对赌博的定义。报道还称，詹姆斯补充说，这两家公司还允许 18 至 20 岁的年轻人使用其平台，违反了该州移动体育博彩 21 岁的最低年龄限制。 报道称，詹姆斯的目标是追回非法所得，处以三倍于非法所得的民事罚款，并向客户进行赔偿，同时禁止 Coinbase 和 Gemini 允许 21 岁以下的人进行投注。 Coinbase告诉，预测市场是受联邦监管的全国性交易所，已在美国商品期货交易委员会（CFTC）注册。“Coinbase将继续争取国会所期望的对这些市场进行联邦监管，”首席法务官Paul Grewal表示。 Gemini Titan尚未回复的置评请求。 （市场闲谈新闻来源于与全球市场专业人士的对话。这些信息被认为来自可靠来源，但可能包含传闻和推测。准确性无法保证。）

Price: $198.34, Change: $-13.29, Percent Change: -6.28%

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895